Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)

CAS : 54965-24-1

Ref. IN-DA00ILKV

Informations sur le produit

• Nom: Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)
• Synonymes: [u'Citrate, Tamoxifen', u'ICI 46,474', u'ICI 46474', u'ICI 47699', u'ICI-46,474', u'ICI-46474', u'ICI-47699', u'ICI46,474', u'ICI46474', u'ICI47699', u'Nolvadex', u'Novaldex', u'Soltamox', u'Tamoxifen', u'Tamoxifen Citrate', u'Tomaxithen', u'Zitazonium', u'Tamoxifen citrate', u'54965-24-1', u'Istubal', u'Tamoxifen (Citrate)', u'Zitazonium', u'UNII-7FRV7310N6', u'Tamoxifen citrate salt', u'ICI 46474 citrate', u'Farmifeno', u'Ginarsan', u'Jenoxifen', u'Ledertam', u'Nourytan', u'Noxitem', u'Oncotam', u'Tafoxen', u'Tamofen', u'Tamoplex', u'Tamoxasta', u'Tamoxifen Citrate (Nolvadex)', u'Terimon', u'Zynoplex', u'Emblon', u'Nolgen', u'Noltam', u'Zemide', u'Genox', u'Tamax', u'Taxus', u'Tamox-Puren', u'7FRV7310N6', u'Z-Tamoxifen citrate', u'MFCD00058321', u'NSC180973', u'NCGC00024928-06', u'CAS-54965-24-1', u'Tamoxifen citrate, 98%', u'ICI 46474', u'DSSTox_CID_1301', u'DSSTox_RID_76068', u'DSSTox_GSID_21301', u'CCRIS 6718', u'Caditam', u'Tamoxifencitrate', u'EINECS 259-415-2', u'ICI 46,474', u'SMR000677949', u'SR-01000075523', u'I.C.I. 46474 citrate', u'citro; tamoxifen', u'trans-1-(p-beta-Dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-ene citrate', u'(Z)-2-(p-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1)', u'2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid', u'Prestwick_458', u'Tamoxifen citrate [USAN:USP:JAN]', u'Tamoxifen (Nolvadex)', u'Tamoxifen Citrate,(S)', u'Tamoxifen, citrate salt', u'AC1MBZ3O', u'Lopac-T-9262', u'Tamoxifen Z-isomer citrate', u'CHEMBL786', u'SCHEMBL6365', u'Tamoxifen-Citrate(Nolvadex)', u'MLS001055370', u'MLS002154210', u'ARONIS23853', u'SPECTRUM1500557', u'Nolvadex (TN) (AstraZeneca)', u'DTXSID8021301', u'Tamoxifen citrate (JP17/USP)', u'HMS500M20', u'Tamoxifen citrate salt, >=99%', u'FQZYTYWMLGAPFJ-OQKDUQJOSA-N', u'HMS1568M14', u'HMS1921C13', u'HMS2092K17', u'HMS2095M14', u'HMS2232E08', u'HMS3263B08', u'HMS3675P04', u'HMS3712M14', u'Pharmakon1600-01500557', u'(2-{4-[1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine; 2-hydroxypropane-1,2,3-tricarboxylic acid', u'(Z)-(2-(4-(1,2-Diphenylbut-1-enyl)phenoxy)ethyl)dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate', u'2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)', u'hydroxypropane-1,2,3-tricarboxylate', u'Tox21_110938', u'Tox21_202070', u'Tox21_300274', u'Tox21_501203', u'CCG-39629', u'N,N-Dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)ethylamine citrate', u'NSC757345', u's1238', u's1972', u'SBB080554', u'AKOS005111126', u'Tox21_110938_1', u'CS-1852', u'KS-5046', u'LP01203', u'NSC-180973', u'NSC-757345', u'Ethylamine, 2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, citrate (Z)-', u'NCGC00016206-01', u'NCGC00016206-02', u'NCGC00016206-03', u'NCGC00016206-04', u'NCGC00016206-05', u'NCGC00016206-06', u'NCGC00024928-02', u'NCGC00024928-23', u'NCGC00094450-01', u'NCGC00094450-02', u'NCGC00094450-03', u'NCGC00094450-04', u'NCGC00254000-01', u'NCGC00259619-01', u'NCGC00261888-01', u'CPD000677949', u'HY-13757', u'LS-68202', u'M936', u'SAM002564256', u'SC-13399', u'BCP0726000223', u'AB0006810', u'AB2000015', u'EU-0101203', u'SW219368-1', u'(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)', u'D00966', u'J10303', u'K-9859', u'T 9262'], (Z)-2-[4-(1,2-Diphenyl-1-Butenyl)Phenoxyl]-N,N-Dimethyl-Ethanamine-Citrate, 1-P-Beta-Dimethylaminoethoxyphenyl-Trans-1,2-Diphenylbut-1-Ene Citrate, 2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt), Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Genox, I.C.I.46474 citrate, Ici 46474, Istubal, Kessar, Noltam, Nolvadex, Nourytam, Soltamox, Tamofen, Tamoplex, Tamox-Puren, Tamoxiphen Citrate, Tomaxasta, Valodex, Z-Tamoxifen citrate, Zemide
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 563.6381
• Formule: C₃₂H₃₇NO₈
• Degré de pureté: 99%
• Couleur/Forme: Solid
• InChI: InChI=1S/C26H29NO.C6H8O7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-18H,4,19-20H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-
• Code InChI: FQZYTYWMLGAPFJ-OQKDUQJOSA-N